Home＞REGULATORY
Time Has Arrived to Discuss Formularies at Medical Institutions: MHLW Official(May.23.2017)
Katsuaki Ura, deputy director of the Medical Economics Division |
Katsuaki Ura, deputy director of the Medical Economics Division of the Ministry of Health, Labor and Welfare’s (MHLW) Health Insurance Bureau, said on May 20 that “it’s time to begin discussing formularies (lists of recommended drugs) taking a number of factors into account including cost.” He said he looks forward to discussions on introducing formularies at hospitals ...
(LOG IN FOR FULL STORY)
-
- Research Group Builds New Pathogenic Variants Database for Japanese Hereditary Breast Cancer Oct.16
-
I/O Pioneers Win Nobel Prize in Medicine; Honjo Prods Japan Firms to Make More Academic Investment at Home
Oct.02
-
New Treatment GL for Statin Intolerance Compiled by Atherosclerosis Society, 3 Other Academic Societies
Oct.01
-
Opdivo Holds Promise as New Option for Malignant Pleural Mesothelioma: Pulmonary Specialist
Sep.21
-
Oncologist Hails Tagrisso Approval for 1st-Line Lung Cancer Treatment
Sep.14
- MHLW Lifts Contraindications for Combined Statin-Fibrate Use in Renal-Impaired Patients(Oct.17)
- Eisai Seals Latin America Pact for Belviq(Oct.17)
- Teva Takeda Launches Voluntary Recall for Taxotere Generics(Oct.17)
- ADR Victim Relief Claims Fall below 1,500 in FY2017: MHLW(Oct.17)
- Japan Wholesaler Chief Suzuki Becomes IFPW Chairman(Oct.16)
